Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Genpact (G) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Genpact (G) over the last 8 years, with Sep 2025 value amounting to $177.2 million.

  • Genpact's Shares Outstanding (Diluted Average) fell 2.02% to $177.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.2 million, marking a year-over-year decrease of 2.02%. This contributed to the annual value of $180.4 million for FY2024, which is 2.54% down from last year.
  • As of Q3 2025, Genpact's Shares Outstanding (Diluted Average) stood at $177.2 million, which was down 0.31% from $177.7 million recorded in Q2 2025.
  • Over the past 5 years, Genpact's Shares Outstanding (Diluted Average) peaked at $193.2 million during Q1 2021, and registered a low of $177.2 million during Q3 2025.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $182.1 million, with a median of $181.4 million in 2024.
  • Data for Genpact's Shares Outstanding (Diluted Average) shows a maximum YoY declined of 3.01% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Genpact's Shares Outstanding (Diluted Average) stood at $193.0 million in 2021, then dropped by 2.53% to $188.1 million in 2022, then decreased by 1.57% to $185.1 million in 2023, then dropped by 2.54% to $180.4 million in 2024, then dropped by 2.02% to $177.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $177.2 million for Q3 2025, versus $177.7 million for Q2 2025 and $178.4 million for Q1 2025.